Research from the University of Michigan showed that Terahertz light can be used to probe both the structures of molecular crystals and their twists.
Research from the University of Michigan has demonstrated that twirling infrared light can be used to probe the structures of molecular crystals. The finding, reported in a March 21, 2022 announcement issued by the university, addresses one of the difficulties associated with drug development, which is determining if drugs and supplements with chiral structures are turning in the correct direction.
Drugs containing molecules with the wrong twist can cause unpleasant or dangerous side effects. According to the university’s announcement, this method uses terahertz radiation, a portion of the infrared part of the spectrum, to quickly recognize wrong twists and wrong chemical structures in packaged drugs.
Researchers hope that the technique can also be used to find harmful accumulations of twisted molecules in the body. This could help diagnose bladder stones, insulin fibrils, and amyloid aggregations such as the plaques that appear in Alzheimer’s disease, according to the university’s announcement.
“We foresee new roads ahead—for instance, using terahertz waves with tailored polarization to manipulate large molecular assemblies,” said André Farias de Moura, professor of chemistry at the Federal University of São Carlos, in the announcement. “It might replace microwaves in many synthesis applications in which the handedness of the molecules matters.”
The technique was developed by an international team consisting of researchers from Federal University, the Brazilian Biorenewables National Laboratory, the University of Notre Dame, and Michigan State University.
Source: University of Michigan
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Hesperos, Psilera Agree to Accelerate Organ-on-a-Chip Treatment for Frontotemporal Dementia
June 9th 2025The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options are few.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
How Smart Technology is Helping Reach Sustainability Goals in Drug Packaging
June 7th 2025Smart technologies, such as digital and laser printing, incorporated into manufacturing equipment are helping manufacturers align with sustainability goals, according to Sheikh Akbar Ali, general manager and head of Development and Technology for ACG Packaging Materials.